Search

Author/Creator Li, Yasong

3. Disease activity guided stepwise tapering or discontinuation of rhTNFR:Fc, an etanercept biosimilar, in patients with ankylosing spondylitis: a prospective, randomized, open-label, multicentric study. (May 2020)

Authors:
Zhang, Ting; Zhu, Jianing; He, Dongyi; Chen, Xiaowei; Wang, Hongzhi; Zhang, Ying; Xue, Qin; Liu, Weili; Xiang, Guangbo; Li, Yasong; Yu, Zhongming; Wu, Huaxiang
Journal:
Therapeutic advances in musculoskeletal disease
Issue:
Volume 12(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Disease activity guided stepwise tapering or discontinuation of rhTNFR:Fc, an etanercept biosimilar, in patients with ankylosing spondylitis: a prospective, randomized, open-label, multicentric study. (May 2020)

Authors:
Zhang, Ting; Zhu, Jianing; He, Dongyi; Chen, Xiaowei; Wang, Hongzhi; Zhang, Ying; Xue, Qin; Liu, Weili; Xiang, Guangbo; Li, Yasong; Yu, Zhongming; Wu, Huaxiang
Journal:
Therapeutic advances in musculoskeletal disease
Issue:
Volume 12(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Disease activity guided stepwise tapering or discontinuation of rhTNFR:Fc, an etanercept biosimilar, in patients with ankylosing spondylitis: a prospective, randomized, open-label, multicentric study. (May 2020)

Authors:
Zhang, Ting; Zhu, Jianing; He, Dongyi; Chen, Xiaowei; Wang, Hongzhi; Zhang, Ying; Xue, Qin; Liu, Weili; Xiang, Guangbo; Li, Yasong; Yu, Zhongming; Wu, Huaxiang
Journal:
Therapeutic advances in musculoskeletal disease
Issue:
Volume 12(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Disease activity guided stepwise tapering or discontinuation of rhTNFR:Fc, an etanercept biosimilar, in patients with ankylosing spondylitis: a prospective, randomized, open-label, multicentric study. (May 2020)

Authors:
Zhang, Ting; Zhu, Jianing; He, Dongyi; Chen, Xiaowei; Wang, Hongzhi; Zhang, Ying; Xue, Qin; Liu, Weili; Xiang, Guangbo; Li, Yasong; Yu, Zhongming; Wu, Huaxiang
Journal:
Therapeutic advances in musculoskeletal disease
Issue:
Volume 12(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Genetic predictors of efficacy and toxicity of iguratimod in patients with rheumatoid arthritis. (April 2018)

Authors:
Xiao, Wenjing; Guo, Jian-Ping; Li, Chun; Ye, Hua; Wei, Wei; Zou, Yaohong; Dai, Lie; Li, Zhijun; Zhang, Miaojia; Li, Xiangpei; Cai, Xiaoyan; Zhao, Jianhong; Wang, Youlian; Tao, Yi; Liu, Dongzhou; Li, Yasong; Wu, Min; Sun, Erwei; Wu, Lijun; Luo, Li
Journal:
Pharmacogenomics
Issue:
Volume 19:Number 5(2018)
Page Start:
383
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Hypouricemic and arthritis relapse-reducing effects of compound tufuling oral-liquid in intercritical and chronic gout: A double-blind, placebo-controlled, multicenter randomized trial. Issue 11 (March 2017)

Authors:
Xie, Zhijun; Wu, Huaxiang; Jing, Xiaoqing; Li, Xiuyang; Li, Yasong; Han, Yongmei; Gao, Xiangfu; Tang, Xiaopo; Sun, Jing; Fan, Yongshen; Wen, Chengping
Other Names:
Pany. Satyabrata section editor.
Journal:
Medicine
Issue:
Volume 96:Issue 11(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗